Mss4 gene is up-regulated in rat brain after chronic treatment with antidepressant and down-regulated when rats are

Christian Andriamampandry1, Claude Muller, Catherine Schmidt-Mutter

  • 1Institut de Chimie Biologique, U-338, Faculty of Medicine, Strasbourg, France.

Molecular Pharmacology
|November 19, 2002
PubMed

Insights

Chronic antidepressant treatment, including imipramine, tianeptine, and fluoxetine, upregulates the Mss4 gene in rat brains. This suggests Mss4 protein plays a role in antidepressant action and neurotransmitter pathway potentiation.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Antidepressant medications are crucial for treating mood disorders.
  • The precise molecular mechanisms underlying antidepressant efficacy remain incompletely understood.
  • Identifying common molecular targets of various antidepressants can elucidate therapeutic pathways.

Purpose of the Study:

  • To identify genes differentially expressed in the rat brain following chronic treatment with the antidepressant imipramine.
  • To investigate the role of the identified genes in the mechanisms of action of different classes of antidepressants.
  • To explore the involvement of these genes in stress-induced anhedonia.

Main Methods:

  • Differential display reverse transcription-polymerase chain reaction (DD-RT-PCR) was employed to screen for differentially expressed mRNAs.
  • Northern blot analysis and in situ hybridization were used to quantify and localize gene expression.
  • Anhedonia was induced in rats using a chronic mild stress model.

Main Results:

  • The mutation suppressor for Sec4-8 yeast (Mss4) transcript was found to be significantly overexpressed in the amygdala and hippocampus of rats treated with imipramine, tianeptine, or fluoxetine.
  • Mss4 protein functions as a guanine nucleotide exchange factor, interacting with Rab proteins involved in neurotransmitter exocytosis.
  • Mss4 transcripts were downregulated in the hippocampus and amygdala of rats subjected to chronic mild stress, a model of anhedonia.

Conclusions:

  • Mss4 gene expression is upregulated by chronic administration of multiple antidepressants, suggesting it is a common molecular target.
  • Mss4 protein's role in stimulating exocytosis indicates its involvement in potentiating neurotransmitter pathways crucial for antidepressant action.
  • Mss4 may represent a key functional molecule induced by chronic antidepressant treatments and implicated in mood regulation.

Related Concept Videos